Deferasirox 59651-0449
Product NDC
59651-0449- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Granule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 8, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA215137
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 360 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
30 PACKET in 1 CARTON (59651-449-30) / 1 GRANULE in 1 PACKET (59651-449-54)